Active, not recruiting
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
NCT05617677
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
- Locations
-
- Local Institution - 0012 Birmingham, Alabama, United States
- Local Institution - 0229 Phoenix, Arizona, United States
- Local Institution - 0193 Tucson, Arizona, United States
- Kaiser Permanente Fontana, California, United States